Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection

Summary

The purpose of this study is to assess if the use of Envarsus in place of Tacrolimus-immediate release (IR) in rapid metabolizers post kidney transplant will reduce incidence of BK infection. Efficacy evaluations will include measurement of urine and serum BK values at specified time points and review of any biopsy for BK virus nephropathy. Incidence of rejection, graft failure, and graft dysfunction will also be measured at specified time points.

Timeline

Start

2019-05-09

Primary completion

2022-03-16

Completion

2022-03-16

Drugs

Indications